Do You Need To Make Tough Decisions About Your Pharmaceutical Marketing?


In the HealthCare Industry today, economic and financial pressures are shrinking profit margins, intensifying competition and constraining the funds available for corporate and marketing investments. Consequently, HealthCare executives throughout the Industry must confront difficult choices.


Our Clients first call us when they have something challenging to deal with, whether it is a new launch, turning around a declining market share, knowing how to allocate budget after a budget cut, defending against Generic or other Branded competitors, or assessing a major strategic challenge. Our Clients turn to us when they find themselves under pressure to deliver measurable results in challenging situations. Our Clients turn to us when information is difficult to get, when insights are scarce and current approaches are not delivering the desired results. Our Clients turn to us when they need to make decisions that will have major consequences for their brands, either locally or globally.


You can find solutions for your Pre-launch Marketing Effectiveness and ROI and Post-launch Brand Marketing, or Corporate Marketing challenges Corporate Marketing challenges. The bedrock of our company is our 94.8 Analytics Process, which is a unique, predictive, marketing analytics system. It delivers the highest degree of accuracy in the Pharmaceutical market today by analyzing current data - not historical - and delivers what levers are influencing prescribing, how well your brand (and your competitors) are doing on these, and what needs to be changed to grow a brand's market share (and profit) by a specific amount. Eularis 94.8 Analytics gives you the bottom line on which of your activities really count and what to do about the ones that do not. See what our Clients say about us for further evidence of the real benefits of the 94.8 Analytics advanced technology.

"It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions."

Brand Manager, GlaxoSmithKline

BY WORKING WITH EULARIS, YOU WILL GAIN:

IMPROVED PLANNING

  • Confidently plan your performance against your forecasts

  • Reveal how, when and where to spend your budget for the optimal and measurable results

  • Create accurate investment scenarios to predict ROI if changes occur

  • Quantify the potential impact from each activity before launch.


IMPROVED ANALYTICS

  • Understand how to analyze and optimize your messages and activities for the current market situation rather than historically

  • Evaluate which messages have the most impact on actual prescribing

  • Highlight rep quality differences across competitor brands

  • Understand how to allocate budget across activities for a specific growth

  • Change your analytics process to a dynamic, forward-looking strategy based on the current market situation, rather than one based on inaccurate historical data


IMPROVED RESULTS

  • Build 94.8 Analytics into your management systems for rapid and reliable response to internal and external change

  • Improve your Pharma Marketing ROI to meet your business objectives

  • Identify opportunities to re-allocate brand and corporate marketing investments

  • Grow your brand market share measurably with confidence


WHY INVEST IN 94.8 ANALYTICS?

  • Independent research showed an accuracy of 94.8% over several years

  • The system pays for itself with a resulting rise in Client brand market share due to its accurate message focus and marketing mix allocation

  • You get specific, key, actionable information that will have maximum impact on your brand sales/market share over the next 6 -12 months

  • The system is continually updated to remain state-of-the-art


WHY ARE OUR ANALYTICS DIFFERENT FROM OTHER ANALYTICS?

After the great stock market crash of the 80's, according to respected sources such as The Economist, it was evident that only a handful of people in the world had predicted it. None of these were Technical Analysts using solely "hard" econometric data in their calculations. This is not a criticism of traditional old school Analysts. It is simply that, without taking the changing current market dynamics into account (by using solely hard economic data from previous points in time), accurate predictions could not be made. Some analytical models rely on taking 3-5 historical data points to predict future performance scenarios. However, this does not take into account changing market dynamics that are inherent in an environment such as Pharmaceuticals - Market dynamics such as new competitors, new competitor actions, changing regulations, decreased impact of activities, and more.

The bottom line is that, without access to clear dynamic, current market data, analyzed hand-in-hand with the "hard" financial data in predictive analytics, it remains impossible for company executives to effect change with any real degree of certainty that their efforts will produce the right results. By incorporating current market data, Pharmaceutical companies can now use these powerful analytical tools to provide real and actionable data on corporate performance and sales and marketing activities performance, and what it will mean for their market share, in a format that top executives can buy into and trust. Our 94.8 Analytics System collects current up-to-date market data, feeds this into "hard" data such as market shares, etc. to provide a prediction that has the highest degree of mathematical certainty possible.

This model has been proven for many years to be the most mathematically accurate way available to really predict market position and brand market share in advance. The 94.8 Analytics System continues to be fine-tuned by the mathematicians, and added to, to take into account additional Client needs.

This mathematical tool enables a powerful approach to generate predictive models of performance, based on real market activities at this point in time (and not simply historically) that they can easily interpret. This 94.8 Analytics System has been successfully used with Pharmaceutical brand marketing activities to impact brand market share with an impressive record.

BEGIN PUTTING THE POWER OF 94.8 BRAND MARKETING ANALYTICS TO WORK FOR YOU


CLICK HERE for a free demonstration of our products on leading company brands.

Marketing & Sales Analytics
Corporate Performance Analytics
Market Reports
Workshops/Training
Consulting


'The 9 Survival
Secrets that Every Pharmaceutical Marketing Professional Has to Know to Thrive in 2009'

 

Download Free Report Here

* Email
* First Name
* Phone
* ROI Challenge
* = Required Field

Only company email addresses are accepted for this so if you use your hotmail, yahoo, gmail, aol, comcast etc. email addresses, they will be rejected.

Your email address will be 100% protected and will never, ever be shared.

Only available to employees of Healthcare Companies including Pharmaceutical, Biotech, Medical Devices, Animal Health. If you have a Healthcare brand to market or sell, then you are likely to get in.

'The 9 Survival
Secrets that Every Pharmaceutical Marketing Professional Has to Know to Thrive in 2009'

Download Free Report Here

* Email
* First Name
* Phone
* ROI Challenge
* = Required Field

Only company email addresses are accepted for this so if you use your hotmail, yahoo, gmail, aol, comcast etc. email addresses, they will be rejected.

Your email address will be 100% protected and will never, ever be shared.

Only available to employees of Healthcare Companies including Pharmaceutical, Biotech, Medical Devices, Animal Health. If you have a Healthcare brand to market or sell, then you are likely to get in.

What Our Clients Say

"Powerful stuff. In my 20 years of marketing I have never seen such valuable data."
Specialist Team Leader, Pfizer

It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions.
Brand Manager, GSK

"The analytics from Eularis, in combination with their analytics products, have provided a foundation for many of our corporate performance metrics as well as our brand marketing ROI metrics."
Senior Vice President, Pfizer